Pages that link to "Q27860648"
Jump to navigation
Jump to search
The following pages link to Sipuleucel-T immunotherapy for castration-resistant prostate cancer (Q27860648):
Displaying 50 items.
- Emerging molecularly targeted therapies in castration refractory prostate cancer (Q21284745) (← links)
- Sipuleucel-T for metastatic castration-resistant prostate cancer (Q24186731) (← links)
- Interleukin-15 biology and its therapeutic implications in cancer (Q24595605) (← links)
- New strategies in metastatic prostate cancer: targeting the androgen receptor signaling pathway (Q24603649) (← links)
- Abiraterone in metastatic prostate cancer without previous chemotherapy (Q24612084) (← links)
- The genomic complexity of primary human prostate cancer (Q24617949) (← links)
- Interdisciplinary critique of sipuleucel-T as immunotherapy in castration-resistant prostate cancer (Q24630999) (← links)
- Sipuleucel-T for metastatic castration-resistant prostate cancer (Q26471816) (← links)
- Immunobiology and immunotherapy in genitourinary malignancies (Q26738668) (← links)
- Galeterone for the treatment of advanced prostate cancer: the evidence to date (Q26739887) (← links)
- Effects of Adoptive Transfer of Tolerogenic Dendritic Cells on Allograft Survival in Organ Transplantation Models: An Overview of Systematic Reviews (Q26739998) (← links)
- CD8 T Cell-Independent Antitumor Response and Its Potential for Treatment of Malignant Gliomas (Q26740520) (← links)
- Immune Checkpoint Inhibitors and Prostate Cancer: A New Frontier? (Q26740601) (← links)
- A Perspective of Immunotherapy for Prostate Cancer (Q26741277) (← links)
- Inhibiting Immune Checkpoints for the Treatment of Bladder Cancer (Q26744758) (← links)
- Immune Cells in Cancer Therapy and Drug Delivery (Q26747061) (← links)
- Perspectives on sipuleucel-T: Its role in the prostate cancer treatment paradigm (Q26747699) (← links)
- Therapeutic Rationales, Progresses, Failures, and Future Directions for Advanced Prostate Cancer (Q26750620) (← links)
- The Present and Future of Biomarkers in Prostate Cancer: Proteomics, Genomics, and Immunology Advancements (Q26750672) (← links)
- Cancer immunotherapy: the beginning of the end of cancer? (Q26752277) (← links)
- Tremelimumab: research and clinical development (Q26752822) (← links)
- A primer on tumour immunology and prostate cancer immunotherapy (Q26765697) (← links)
- Contemporary Management of Prostate Cancer (Q26767456) (← links)
- Novel cancer antigens for personalized immunotherapies: latest evidence and clinical potential (Q26769884) (← links)
- Prostate Cancer for the Internist (Q26771721) (← links)
- Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines (Q26772715) (← links)
- Patient experience in the treatment of metastatic castration-resistant prostate cancer: state of the science (Q26772883) (← links)
- Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Prostate Cancer: A Systematic Review and Meta-analysis (Q26773406) (← links)
- Sequence of treatment in locally advanced and metastatic renal cell carcinoma (Q26773653) (← links)
- Dendritic Cells in Oncolytic Virus-Based Anti-Cancer Therapy (Q26774345) (← links)
- RNA-Based Vaccines in Cancer Immunotherapy (Q26776028) (← links)
- Immunotherapeutic approaches in biliary tract carcinoma: Current status and emerging strategies (Q26776184) (← links)
- Peptide-Based Treatment: A Promising Cancer Therapy (Q26777032) (← links)
- Fueling the engine and releasing the break: combinational therapy of cancer vaccines and immune checkpoint inhibitors (Q26778793) (← links)
- Role of Dendritic Cells in the Induction of Lymphocyte Tolerance (Q26779405) (← links)
- Targeting Transcriptional Regulators of CD8+ T Cell Dysfunction to Boost Anti-Tumor Immunity (Q26782201) (← links)
- Nanoparticle Drug Delivery Systems Designed to Improve Cancer Vaccines and Immunotherapy (Q26782566) (← links)
- Cancer Dormancy: A Regulatory Role for Endogenous Immunity in Establishing and Maintaining the Tumor Dormant State (Q26782573) (← links)
- The Promise of Preventive Cancer Vaccines (Q26783742) (← links)
- Immune Reactivation by Cell-Free Fetal DNA in Healthy Pregnancies Re-Purposed to Target Tumors: Novel Checkpoint Inhibition in Cancer Therapeutics (Q26784480) (← links)
- Immune Checkpoint Blockade: A New Paradigm in Treating Advanced Cancer (Q26795509) (← links)
- Antagonists of PD-1 and PD-L1 in Cancer Treatment (Q26796311) (← links)
- ODM-201: a new-generation androgen receptor inhibitor in castration-resistant prostate cancer (Q26796568) (← links)
- The progress of immunotherapy for glioblastoma (Q26797282) (← links)
- Application of radiation technology in vaccines development (Q26798165) (← links)
- Immunosuppressive Mechanisms of Malignant Gliomas: Parallels at Non-CNS Sites (Q26798402) (← links)
- Immune Infiltration and Prostate Cancer (Q26798412) (← links)
- Molecular landscape of prostate cancer: implications for current clinical trials (Q26799585) (← links)
- Development of sipuleucel-T: autologous cellular immunotherapy for the treatment of metastatic castrate resistant prostate cancer (Q26823559) (← links)
- Beyond empiricism: informing vaccine development through innate immunity research (Q26824573) (← links)